Study on Optimizing the Treatment of Patients With Acute Myeloid Leukemia Based on Early Peripheral Blood Minimal Residual Disease

Clinical trial NCT07023588 · RECRUITING

Trial details

NCT number: NCT07023588
Sponsor: Yehui Tan
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)

Start date: 2025-06-01
Primary completion: 2029-05-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.